• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原位滤泡 B 细胞肿瘤表现为粟粒状面部丘疹:一种独特的临床表现和自发消退。

In Situ Follicular B-Cell Neoplasm Presenting as Miliary Facial Papules: A Unique Clinical Presentation and Spontaneous Regression.

机构信息

Department of Pathology, Division of Hematopathology, University of Calgary; and.

Department of Medicine, Division of Dermatology, University of Calgary.

出版信息

Am J Dermatopathol. 2024 Mar 1;46(3):167-169. doi: 10.1097/DAD.0000000000002579. Epub 2023 Oct 26.

DOI:10.1097/DAD.0000000000002579
PMID:37910140
Abstract

In situ follicular B-cell neoplasm (ISFN) is a variant of follicular lymphoma, presenting as an incidental histologic finding in lymph node biopsy or excisional specimens. ISFN presents with a B-cell population that strongly expresses BCL2 and CD10 within the germinal centers of a lymph node or extranodal site. Genetic analysis shows t(14;18) translocation. Herein, we report a case of ISFN presenting as military and agminated facial papules in a young woman, which resolved spontaneously in the postpartum period. To our knowledge, this is the only report of a cutaneous site of involvement of this rare entity.

摘要

原位滤泡性 B 细胞肿瘤(ISFN)是滤泡性淋巴瘤的一种变体,表现为偶然发现的淋巴结活检或切除标本中的组织学表现。ISFN 表现为 B 细胞群体,在淋巴结或结外部位的生发中心内强烈表达 BCL2 和 CD10。基因分析显示 t(14;18)易位。本文报告了一例 ISFN,表现为年轻女性的多发性军事性面部丘疹,在产后期间自发消退。据我们所知,这是该罕见实体累及皮肤部位的唯一报道。

相似文献

1
In Situ Follicular B-Cell Neoplasm Presenting as Miliary Facial Papules: A Unique Clinical Presentation and Spontaneous Regression.原位滤泡 B 细胞肿瘤表现为粟粒状面部丘疹:一种独特的临床表现和自发消退。
Am J Dermatopathol. 2024 Mar 1;46(3):167-169. doi: 10.1097/DAD.0000000000002579. Epub 2023 Oct 26.
2
Lymphoid follicle colonization by Bcl-2(bright+)CD10(+) B-cells ("follicular lymphoma in situ") at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma.Bcl-2(明亮+)CD10(+)B 细胞(“原位滤泡性淋巴瘤”)在淋巴结和结外部位的淋巴滤泡定植可能是淋巴瘤滤泡归巢的表现。
Hum Pathol. 2013 Jul;44(7):1328-40. doi: 10.1016/j.humpath.2012.10.022. Epub 2013 Jan 28.
3
In situ follicular neoplasm discovered as an enlarging pulmonary nodule complicated by pulmonary aspergillosis.在增大的肺结节中发现的原位滤泡性肿瘤,该结节并发肺曲霉病。
Thorac Cancer. 2023 May;14(15):1401-1403. doi: 10.1111/1759-7714.14878. Epub 2023 Apr 3.
4
In situ follicular lymphoma associated with overt B- or T-cell lymphomas in the same lymph node.同一淋巴结中伴有明显 B 或 T 细胞淋巴瘤的滤泡性淋巴瘤原位病变。
Am J Hematol. 2011 Dec;86(12):E66-70. doi: 10.1002/ajh.22169. Epub 2011 Sep 28.
5
Precursory or early lesions of follicular lymphoma: clinical features, pathology, and genetics.滤泡性淋巴瘤的前驱或早期病变:临床特征、病理学和遗传学。
J Clin Exp Hematop. 2023;63(2):65-72. doi: 10.3960/jslrt.23010.
6
Clinicopathological features of in situ follicular neoplasm and relations with follicular lymphoma in Japan.日本滤泡性肿瘤原位与滤泡性淋巴瘤的临床病理特征及关系。
Ann Hematol. 2020 Feb;99(2):241-253. doi: 10.1007/s00277-019-03841-5. Epub 2020 Jan 2.
7
B-cell follicular lymphoma presenting as facial papules.表现为面部丘疹的B细胞滤泡性淋巴瘤。
J Dtsch Dermatol Ges. 2018 Dec;16(12):1493-1495. doi: 10.1111/ddg.13692. Epub 2018 Nov 12.
8
Follicular and mantle cell lymphoma characteristics present simultaneously in the same lymph node.滤泡性淋巴瘤和套细胞淋巴瘤的特征同时出现在同一个淋巴结中。
Appl Immunohistochem Mol Morphol. 2013 Dec;21(6):572-6. doi: 10.1097/PAI.0b013e3182582bd8.
9
Two for One: B-Cell Lymphomas with Features of Marginal and Follicular Lymphomas.合二为一:具有边缘区和滤泡性淋巴瘤特征的B细胞淋巴瘤
Acta Haematol. 2018;139(2):84-88. doi: 10.1159/000486360. Epub 2018 Feb 6.
10
Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort.原位滤泡性肿瘤的发病率、临床病理特征和遗传学:一项日本队列的综合筛查研究。
Histopathology. 2022 Apr;80(5):820-826. doi: 10.1111/his.14617. Epub 2022 Feb 22.